With the stock's current price at Rs 2819.60, GlaxoSmithKline Pharmaceuticals is navigating through market dynamics, ...

The NIFTY MIDCAP 150's movements reflect ongoing market dynamics, with Global Health, JSW Infra, and GlaxoSmithKline ...

GlaxoSmithKline Pharmaceuticals Ltd. reported a 36% increase in consolidated net profit to Rs 263 crore for the quarter ended ...

UnitedHealth Group said Chief Executive Andrew Witty stepped down for “personal reasons” after presiding over a punishing ...

India's GlaxoSmithKline Pharmaceuticals reported a higher fourth-quarter profit on Tuesday, led by steady demand for its ...

The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a ...

UnitedHealth Group CEO Andrew Witty is stepping down from his post for personal reasons and the healthcare giant says it’s ...

GlaxoSmithKline Pharmaceuticals reported a 36% rise in consolidated net profit to Rs 263 crore in the March quarter, driven by strong growth in its diversified portfolio. Revenue also increased to Rs ...

GlaxoSmithKline Pharmaceuticals on Tuesday said its consolidated net profit increased 36 per cent to Rs 263 crore during the March quarter. The company rep ...

Discover the details about Andrew Witty’s life, such as his educational qualifications, career graph, major achievements, ...

Glaxosmithkline Pharmaceutical advanced 3.21% to Rs 2,879.70 after the company's standalone net profit jumped 34.73% to Rs 260.14 crore on a 6.06% increase in revenue from operations to Rs 966.08 ...